Mycophenolic Sodium
Mycophenolic Sodium (Myfortic) Only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe mycophenolate sodium. Prophylaxis of Organ Rejection in Kidney Transplant (Myfortic) mycophenolic acid is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant. Myfortic is indicated for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant. Myfortic is to be used in combination with cyclosporine and corticosteroids
USFDA Manufacturer : Zydus Healthcare
Delivery Time : Express Shipping ( 5 to 12 working days)
Expiry : 2016
Manufacturer: Zydus Healthcare
Availability: In Stock
Rating: 1 Reviews / Write a review
Mycophenolic Sodium 360 mg
No of Units | Price / Unit | Price | Free Bonus | |
---|---|---|---|---|
30 Pills | $3.00 | $90.00 | ||
60 Pills | $2.90 | $174.00 | ||
90 Pills | $2.80 | $252.00 | ||
120 Pills | $2.70 | $324.00 |
No of Units | Price | |
---|---|---|
30 Pills | $90.00 | |
60 Pills | $174.00 | |
90 Pills | $252.00 | |
120 Pills | $324.00 |
Mycophenolic Sodium Myfortic (mycophenolic acid) delayed-release tablets are an enteric formulation of mycophenolate sodium that delivers the active moiety mycophenolic acid (MPA). Myfortic is an immunosuppressive agent. As the sodium salt, MPA is chemically designated as (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4enoic acid sodium salt.